METVIXIA Side Effects

6992364-X | Anxiety, Leukaemia, Malignant Neoplasm Progression
on Sep 01, 2010 Female patient from FRANCE , weighting 116.8 lb, was diagnosed with actinic keratosis, basal cell carcinoma and was treated with Metvixia (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), leukaemia, malignant neoplasm progression. Metvixia dosage: (1 Df Topical). During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ENDOXAN /00021101/ (View Endoxan /00021101/ Review and Endoxan /00021101/ Label ). Patient was hospitalized.

6697801-6 | Erythema, Pain, Photosensitivity Reaction, Skin Oedema
Patient was taking Metvixia (View Usage). Patient had the following side effects: erythema, pain (What is pain?), photosensitivity reaction, skin oedema on Apr 12, 2010 from FRANCE Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with porokeratosis and. Metvixia dosage: (1 Df Topical).

6666762-8 | Blister, Erythema, Pain, Skin Swelling
Adverse event was reported on Mar 18, 2010 by a Female patient taking Metvixia (View Usage) (Dosage: Topical) was diagnosed with actinic keratosis and. Location: UNITED KINGDOM , 74 years of age, weighting 140.0 lb, After Metvixia was administered, patient had the following side effects: blister, erythema, pain (What is pain?), skin swelling. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (View Amiloride Hydrochloride And Hydrochlorothiazide Review and Amiloride Hydrochloride And Hydrochlorothiazide Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6338495-9 | Infection, Oedema Peripheral, Pain In Extremity, Skin Lesion, Wound Secretion
on Aug 18, 2009 Female patient from UNITED KINGDOM , 60 years of age, was diagnosed with porokeratosis and was treated with Metvixia (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), oedema peripheral, pain in extremity, skin lesion, wound secretion. Metvixia dosage: (topical). During the same period patient was treated with ANTIVIRALS NOS () (View Antivirals Nos () Review and Antivirals Nos () Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), LANSOPRAZOL (View Lansoprazol Review and Lansoprazol Label ).


5642662-7 | Angioedema, Dyspnoea, Pharyngeal Oedema, Pruritus
on Feb 12, 2008 Male patient from SWEDEN , 90 years of age, was diagnosed with basal cell carcinoma and was treated with Metvixia (View Usage). Patient had the following side effects: angioedema, dyspnoea, pharyngeal oedema, pruritus. Metvixia dosage: 1 Df Topical Topical. Patient was hospitalized.

5632200-7 | Blepharitis, Erythema, Inflammation, Pain Of Skin
Patient was taking Metvixia (View Usage). After Metvixia was administered, patient had the following side effects: blepharitis, erythema, inflammation, pain of skin on Feb 04, 2008 from SPAIN Additional patient health information: Female patient , 37 years of age, was diagnosed with basal cell carcinoma and. Metvixia dosage: 1 Df Total; Topical.

5584800-0 | Erythema, Rash Pustular, Skin Hyperpigmentation
Adverse event was reported on Dec 19, 2007 by a Male patient taking Metvixia (View Usage) (Dosage: 1 Df Total , Topical) was diagnosed with actinic keratosis and. Location: SWITZERLAND , 58 years of age, Patient experienced the following unwanted or unexpected effects: erythema, rash pustular, skin hyperpigmentation.

5526122-X | Corneal Erosion, Ocular Hyperaemia
on Nov 05, 2007 Male patient from AUSTRALIA , 53 years of age, was diagnosed with actinic keratosis and was treated with Metvixia (View Usage). Patient had the following side effects: corneal erosion, ocular hyperaemia. Metvixia dosage: 2 G Total Topical. During the same period patient was treated with ANAPROX (View Anaprox Review and Anaprox Label ), CELESTONE (BETAMETHASONE) (View Celestone (betamethasone) Review and Celestone (betamethasone) Label ), DIPROSONE (View Diprosone Review and Diprosone Label ).

5480983-1 | Cheilitis, Erythema, Lip Swelling, Pain Of Skin, Post Inflammatory Pigmentation Change, Scab, Scar, Skin Burning Sensation, Skin Swelling
on Sep 24, 2007 Female patient from UNITED KINGDOM , 41 years of age, was treated with Metvixia (View Usage). After Metvixia was administered, patient had the following side effects: cheilitis, erythema, lip swelling, pain of skin, post inflammatory pigmentation change, scab (What is scab?), scar (What is scar?), skin burning sensation, skin swelling. Metvixia dosage: 1 App Once Tp.

5376187-3 | Off Label Use, Pain Of Skin, Rash Pustular, Scab, Skin Swelling
Patient was taking Metvixia (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, pain of skin, rash pustular, scab (What is scab?), skin swelling on Jun 01, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 20 years of age, was diagnosed with acne (What is acne?) and. Metvixia dosage: 4 G.

5363365-2 | Burns Second Degree, Skin Hyperpigmentation, Swelling
Adverse event was reported on May 31, 2007 by a Female patient taking Metvixia (View Usage) (Dosage: Topical) was diagnosed with skin papilloma and. Location: GERMANY , 27 years of age, Patient had the following side effects: burns second degree, skin hyperpigmentation, swelling.

5363359-7 | Burns Second Degree, Off Label Use, Skin Hyperpigmentation, Swelling
on May 31, 2007 Female patient from GERMANY , 27 years of age, was diagnosed with skin papilloma and was treated with Metvixia (View Usage). After Metvixia was administered, patient had the following side effects: burns second degree, off label use, skin hyperpigmentation, swelling. Metvixia dosage: Topical.

5353055-4 | Application Site Pustules, Erythema, Loss Of Employment, Pain Of Skin, Skin Oedema
on May 23, 2007 Female patient from SWITZERLAND , 44 years of age, was diagnosed with actinic keratosis and was treated with Metvixia (View Usage). Patient experienced the following unwanted or unexpected effects: application site pustules, erythema, loss of employment, pain of skin, skin oedema. Metvixia dosage: 1 App Once Tp.

5340021-8 | Burns Second Degree, Skin Hyperpigmentation, Swelling
Patient was taking Metvixia (View Usage). Patient had the following side effects: burns second degree, skin hyperpigmentation, swelling on May 14, 2007 from GERMANY Additional patient health information: Female patient , 27 years of age, was diagnosed with skin papilloma and. Metvixia dosage: Ni Tp.

5314207-2 | Corneal Disorder, Keratitis
Adverse event was reported on Apr 11, 2007 by a Female patient taking Metvixia (View Usage) (Dosage: 1 App Once ; Tp) was diagnosed with actinic keratosis, basal cell carcinoma and. Location: SPAIN , 85 years of age, After Metvixia was administered, patient had the following side effects: corneal disorder, keratitis.

5223383-1 | Dermatitis Contact, International Normalised Ratio Increased, Productive Cough, Skin Burning Sensation
on Jan 12, 2007 Male patient from DENMARK , 65 years of age, was diagnosed with actinic keratosis and was treated with Metvixia (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis contact, international normalised ratio increased, productive cough, skin burning sensation. Metvixia dosage: 1 App Once Tp. Patient was hospitalized.

5104653-4 | Eye Swelling, Keratitis, Scab, Skin Irritation
on Aug 25, 2006 Female patient from GERMANY , 75 years of age, was diagnosed with actinic keratosis and was treated with Metvixia (View Usage). Patient had the following side effects: eye swelling, keratitis, scab (What is scab?), skin irritation. Metvixia dosage: 1 App Once Tp.